+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
RPGLIFE

RPG Life Sciences Share Price

₹2,761.70 +142.1 (5.42%)
59.36% Gain from 52W Low

26 Oct, 2026 3:52 PM (IST)

RPG Life Sciences live price: ₹2,761.70. It opened at ₹2,653 vs previous close ₹2,620; intraday high/low: ₹2,797/₹2,576. The 50 & 200 DMA stand at ₹2,776.30/₹2,504.60.

RPG Life Sciences Performance

  • Today's Low
  • ₹2,576
  • Today's High
  • ₹2,797
  • 52 Week Low
  • ₹1,733
  • 52 Week High
  • ₹3,128
  • Open Price₹2,653
  • Previous Close₹2,620
  • Volume26,277
  • 50 DMA₹2,776.30
  • 100 DMA₹2,660.30
  • 200 DMA₹2,504.60

RPG Life Sciences Chart

Investment Returns

  • Over 1 Month -9.47%
  • Over 3 Month -5.97%
  • Over 6 Month + 35.84%
  • Over 1 Year + 17.28%

Smart Investing Starts Here Start SIP with RPG Life Sciences for Steady Growth!

Invest Now

RPG Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 38.2
  • PEG Ratio
  • -
  • Market Cap Cr
  • 4,568
  • P/B Ratio
  • 7.2
  • Average True Range
  • 150.6
  • EPS
  • 72.3
  • Dividend Yield
  • 0.9
  • MACD Signal
  • -15.8
  • RSI
  • 47.66
  • MFI
  • 49.59

Latest Stock News Updates

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and any other applicable provisions, please note the schedule of earnings call below, for the quarter and half year ended September 30, 2026

RPG Life Sciences Ltd - 532983 - Board Meeting Intimation for For Quarter And Half Year Ended September 30, 2026

RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve unaudited financial results for quarter and half year ended September 30, 2026

RPG Life Sciences Ltd - 532983 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

RPG Life Sciences Financials

RPG Life Sciences Technicals

EMA & SMA

Current Price
₹2,761.70
+ 142.1 (5.42%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹2,812.30
  • 50 Day
  • ₹2,776.30
  • 100 Day
  • ₹2,660.30
  • 200 Day
  • ₹2,504.60

Resistance and Support

2711.7 Pivot Speed
  • R3 3,068.50
  • R2 2,932.90
  • R1 2,847.30
  • S1 2,626.10
  • S2 2,490.50
  • S3 2,404.90

RPG Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-29 Quarterly Results
2026-07-28 Quarterly Results
2026-04-29 Audited Results & Final Dividend
2026-01-27 Quarterly Results
2025-10-17 Quarterly Results
Date Purpose Remarks
2026-07-09 FINAL Rs.24.00 per share(300%)Final Dividend
2025-06-27 SPECIAL Rs.4.00 per share(50%)Special Dividend
2025-06-27 FINAL Rs.20.00 per share(250%)Final Dividend
2024-06-28 FINAL Rs.16.00 per share(200%)Final Dividend
2023-07-21 FINAL Rs.12.00 per share(150%)Final Dividend
View RPG Life Sciences Dividend History Arrow

RPG Life Sciences Shareholding Pattern

72.95%
16.24%
9.89%
0.87%
0.04%

About RPG Life Sciences

RPG Life Sciences is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). View More
  • NSE Symbol
  • RPGLIFE
  • BSE Symbol
  • 532983
  • ISIN
  • INE105J01010

Similar Stocks to RPG Life Sciences

RPG Life Sciences FAQs

RPG Life Sciences share price is ₹2,761 As on 27 October, 2026 | 01:26

The Market Cap of RPG Life Sciences is ₹4567.6 Cr As on 27 October, 2026 | 01:26

The P/E ratio of RPG Life Sciences is 38.2 As on 27 October, 2026 | 01:26

The PB ratio of RPG Life Sciences is 7.2 As on 27 October, 2026 | 01:26

The 52 week High & Low of RPG Life Sciences is ₹3127.8/₹1733 respectively As on 27 October, 2026 | 01:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23